Aetna Statement Regarding Suit Against Abbott Laboratories; Company Agrees to Dismiss Case.Business Editors HARTFORD, Conn.--(BUSINESS WIRE)--May 27, 2004 Aetna (NYSE NYSE See: New York Stock Exchange : AET AET Aetna, Inc. AET After Extra Time AET Actual Evapotranspiration AET Alliance for Environmental Technology AET Alpha-Ethyltryptamine AET Applied Extrusion Technologies, Inc. ) today issued the following statement: "Aetna today agreed to voluntarily dismiss without prejudice Without any loss or waiver of rights or privileges. When a lawsuit is dismissed, the court may enter a judgment against the plaintiff with or without prejudice. When a lawsuit is dismissed without prejudice its lawsuit against Abbott Laboratories. Aetna intends to discuss with Abbott the basis for its repricing Repricing To change the price of an asset. In derivatives, it sometimes refers to the exchange of options of with different strike prices. repricing action." About Aetna As one of the nation's leading providers of health care, dental, pharmacy, group life, disability and long-term care long-term care (LTC), n the provision of medical, social, and personal care services on a recurring or continuing basis to persons with chronic physical or mental disorders. benefits, Aetna puts information and helpful resources to work for its approximately 13.3 million medical members, 11.2 million dental members, 8.1 million pharmacy members and 12.4 group insurance members to help them make better informed decisions about their health care and protect their finances against health-related risks. Aetna provides easy access to cost effective health care through a nationwide network of more than 618,000 health care professionals, including over 370,000 primary care and specialist doctors and 3,783 hospitals. For more information, please visit www.aetna.com. (Figures as of March 31, 2004) |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion